11 Jul, 2013 R&D Day 2013 Podcast and Presentations
On July 11, we hosted an R&D Day in New York City. Alnylam scientists and management reviewed progress with our Alnylam 5×15 pipeline for the development and commercialization of RNAi therapeutics. The event featured presentations by experts in the following disease areas: TTR-Mediated Amyloidosis, Hemophilia and Rare Bleeding Disorders, and Acute Intermittent Porphyria.
Hemophilia and Rare Bleeding Disorders (RBD)
Acute Intermittent Porphyria (RBD)